Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 256 participants.
Also called NCT03667677
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 256 participants
- Sponsor
- Registry
-
NCT03667677
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03667677. Randomized; quadruple masking; primary purpose treatment. Start 2019-02-01 (anticipated); primary completion 2020-02-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety
- Condition
- Hypertension
- Condition
- Anxiety
- Intervention (Drug)
- Tandospirone + Amlodipine
- Intervention (Drug)
- Tandospirone placebo + Amlodipine
- Intervention (Drug)
- Tandospirone + Amlodipine placebo
- Intervention (Drug)
- Tandospirone placebo + Amlodipine placebo
- Lead sponsor
- Chongqing Medical University
Record details
- Record id
cardio:ct-nct03667677- Content hash
36dfc72cf7f40b199aae09271b4f79f0a903dcddb8c43660847eba4d4a0e2d57